Next Article in Journal
Co-Administration of Adjuvanted Recombinant Ov-103 and Ov-RAL-2 Vaccines Confer Protection against Natural Challenge in A Bovine Onchocerca ochengi Infection Model of Human Onchocerciasis
Previous Article in Journal
A Single Dose of ChAdOx1 nCoV-19 Vaccine Elicits High Antibody Responses in Individuals with Prior SARS-CoV-2 Infection Comparable to That of Two-Dose-Vaccinated, SARS-CoV-2-Infection-Naïve Individuals: A Longitudinal Study in Ethiopian Health Workers
 
 
Review

Article Versions Notes

Vaccines 2022, 10(6), 860; https://doi.org/10.3390/vaccines10060860
Action Date Notes Link
article pdf uploaded. 27 May 2022 14:57 CEST Version of Record https://www.mdpi.com/2076-393X/10/6/860/pdf-vor
article xml file uploaded 1 June 2022 13:26 CEST Original file -
article xml uploaded. 1 June 2022 13:26 CEST Update -
article pdf uploaded. 1 June 2022 13:26 CEST Updated version of record https://www.mdpi.com/2076-393X/10/6/860/pdf-vor
article html file updated 1 June 2022 13:27 CEST Original file -
article xml file uploaded 2 June 2022 09:54 CEST Update -
article xml uploaded. 2 June 2022 09:54 CEST Update -
article pdf uploaded. 2 June 2022 09:54 CEST Updated version of record https://www.mdpi.com/2076-393X/10/6/860/pdf-vor
article html file updated 2 June 2022 09:55 CEST Update -
article xml file uploaded 21 June 2022 09:05 CEST Update -
article xml uploaded. 21 June 2022 09:05 CEST Update -
article pdf uploaded. 21 June 2022 09:05 CEST Updated version of record https://www.mdpi.com/2076-393X/10/6/860/pdf-vor
article html file updated 21 June 2022 09:06 CEST Update -
article xml file uploaded 23 June 2022 02:29 CEST Update -
article xml uploaded. 23 June 2022 02:29 CEST Update https://www.mdpi.com/2076-393X/10/6/860/xml
article pdf uploaded. 23 June 2022 02:29 CEST Updated version of record https://www.mdpi.com/2076-393X/10/6/860/pdf
article html file updated 23 June 2022 02:30 CEST Update -
article html file updated 3 August 2022 02:14 CEST Update https://www.mdpi.com/2076-393X/10/6/860/html
Back to TopTop